bpi glp-1 Hims & Hers Selling Injection That's Not FDA Approved, From Shady Supplier — And Won't Make You Talk to a Doctor to Get It or prevent any disease. BPI Labs to Stop Compounding
Description
Four Key Focus Areas Focus 1: GLP-1 Franchise (Mounjaro + Zepbound) Sales Surge Mounjaro (diabetes) and Zepbound (obesity) remain the primary revenue engines
For most folks its a cosmetic issue and nothing more
Dulaglutide Trulicity (Injection) Indication : Type 2 Diabetes, cardiovascular risk reduction Frequency : Weekly 5
Improves metabolic health*
This behavioral foundationnot the medication itselfdetermines your ability to maintain weight loss long-term
